TY  - JOUR
T1  - Notes from the field: Use of tetanus, diphtheria, and pertussis vaccine (tdap) in an emergency department—arizona, 2009-2010
Y1  - 2012/04/25
N1  - 
JO  - JAMA
SP  - 1687
EP  - 1688
VL  - 307
IS  - 16
N2  - 
Because of an increasing incidence of reported pertussis cases attributed to waning immunity among adults and adolescents, the Advisory Committee on Immunization Practices (ACIP) in 2005 recommended administration of a new, combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) for adolescents and adults aged 11-64 years.1 ACIP recommended that they receive a single dose of Tdap to replace tetanus and diphtheria toxoid vaccine (Td) for booster immunization against tetanus and diphtheria if they had not previously received Tdap. Adults aged ≥65 years were to receive Td according to ACIP recommendations.1 To learn whether these age-specific recommendations were being followed in an emergency department (ED), the charts of a sample of patients receiving tetanus vaccines at a large ED were reviewed.

SN  - 0098-7484
M3  - doi: 
UR  - http://dx.doi.org/
ER  -